NASDAQ:CDLX Cardlytics Stock Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Cardlytics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $68.79 +0.87 (+1.28 %) (As of 09/28/2020 12:00 AM ET) Add Compare Share Today's Range$66.62Now: $68.79▼$69.1850-Day Range$64.26MA: $73.22▼$85.7252-Week Range$27.33Now: $68.79▼$107.50Volume541,539 shsAverage Volume759,034 shsMarket Capitalization$1.88 billionP/E RatioN/ADividend YieldN/ABeta2.32 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Cardlytics, Inc. operates a purchase intelligence platform in the United States and the United Kingdom. It operates in two segments, Cardlytics Direct and Other Platform Solutions. The company's platform is the Cardlytics Direct solution, a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. It also provides solutions that enable marketers and marketing service providers to leverage the power of purchase intelligence outside the banking channel. The company was founded in 2008 and is headquartered in Atlanta, Georgia.Read More Beat the Market (BTM) Rank™ 1.0 Analyst's Opinion Consensus RatingCardlytics has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, 4 hold ratings, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of $59.33, Cardlytics has a forecasted downside of 13.7% from its current price of $68.79.Amount of Analyst CoverageCardlytics has only been the subject of 3 research reports in the past 90 days. Previous Next 2.2 Community Rank Outperform VotesCardlytics has received 189 “outperform” votes. (Add your “outperform” vote.)Underperform VotesCardlytics has received 248 “underperform” votes. (Add your “underperform” vote.)Community SentimentCardlytics has received 56.75% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Cardlytics and other stocks. Vote “Outperform” if you believe CDLX will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CDLX will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldCardlytics does not currently pay a dividend.Dividend GrowthCardlytics does not have a long track record of dividend growth. Previous Next 4.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Cardlytics insiders have bought 398.26% more of their company's stock than they have sold. Specifically, they have bought $18,671,681.00 in company stock and sold $3,747,368.00 in company stock.Percentage Held by InsidersOnly 6.50% of the stock of Cardlytics is held by insiders.Percentage Held by Institutions91.40% of the stock of Cardlytics is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Cardlytics are expected to grow in the coming year, from ($2.14) to ($1.42) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Cardlytics is -47.44, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cardlytics is -47.44, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCardlytics has a P/B Ratio of 10.95. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 1.0Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 4.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.57 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Computer programming, data processing, & other computer related Sub-IndustryN/A SectorBusiness Services Current SymbolNASDAQ:CDLX Previous Symbol CUSIPN/A CIK1666071 Webwww.cardlytics.com Phone888-798-5802Debt Debt-to-Equity RatioN/A Current Ratio3.45 Quick Ratio3.45Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$210.43 million Price / Sales8.92 Cash FlowN/A Price / Cash FlowN/A Book Value$6.28 per share Price / Book10.95Profitability EPS (Most Recent Fiscal Year)($0.75) Net Income$-17,140,000.00 Net Margins-18.86% Return on Equity-26.42% Return on Assets-17.67%Miscellaneous EmployeesN/A Outstanding Shares27,286,000Market Cap$1.88 billion Next Earnings Date11/10/2020 (Estimated) OptionableNot Optionable $68.79 +0.87 (+1.28 %) (As of 09/28/2020 12:00 AM ET) 30 days | 90 days | 365 days | Advanced Chart Receive CDLX News and Ratings via Email Sign-up to receive the latest news and ratings for CDLX and its competitors with MarketBeat's FREE daily newsletter. Cardlytics (NASDAQ:CDLX) Frequently Asked Questions How has Cardlytics' stock price been impacted by COVID-19 (Coronavirus)? Cardlytics' stock was trading at $45.83 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, CDLX stock has increased by 50.1% and is now trading at $68.79. View which stocks have been most impacted by COVID-19. Do Wall Street analysts recommend investors buy shares of Cardlytics? 6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardlytics in the last year. There are currently 1 sell rating, 4 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Cardlytics. When is Cardlytics' next earnings date? Cardlytics is scheduled to release its next quarterly earnings announcement on Tuesday, November 10th 2020. View our earnings forecast for Cardlytics. How were Cardlytics' earnings last quarter? Cardlytics Inc (NASDAQ:CDLX) released its quarterly earnings results on Tuesday, August, 4th. The company reported ($0.38) EPS for the quarter, topping the Zacks' consensus estimate of ($0.74) by $0.36. The firm had revenue of $28.22 million for the quarter, compared to analysts' expectations of $30.84 million. Cardlytics had a negative return on equity of 26.42% and a negative net margin of 18.86%. The business's revenue was down 42.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($0.12) EPS. View Cardlytics' earnings history. What price target have analysts set for CDLX? 6 brokerages have issued 12-month price targets for Cardlytics' shares. Their forecasts range from $26.00 to $80.00. On average, they expect Cardlytics' stock price to reach $59.33 in the next year. This suggests that the stock has a possible downside of 13.7%. View analysts' price targets for Cardlytics. Who are some of Cardlytics' key competitors? Some companies that are related to Cardlytics include Legend Biotech (DADA), HUYA (HUYA), DouYu International (DOYU), Medallia (MDLA), Switch (SWCH), Rackspace Technology (RXT), SVMK (SVMK), Tripadvisor (TRIP), Pluralsight (PS), 21Vianet Group (VNET), Internet Initiative Japan (IIJIY), Sabre (SABR), Health Catalyst (HCAT), Model N (MODN) and Kodiak Sciences (EVER). View all competitors. What other stocks do shareholders of Cardlytics own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cardlytics investors own include NVIDIA (NVDA), Square (SQ), Docusign (DOCU), Advanced Micro Devices (AMD), Caterpillar (CAT), Trade Desk (TTD), Walt Disney (DIS), Alibaba Group (BABA), QUALCOMM (QCOM) and Roku (ROKU). Who are Cardlytics' key executives? Cardlytics' management team includes the following people: Mr. Scott D. Grimes, Co-Founder, CEO & Director (Age 56)Ms. Lynne Marie Laube, Co-Founder, COO & Director (Age 49)Mr. David Evans, CFO & Head of Corp. Devel.Mr. Sathish Gaddipati, Chief Technology Officer (Age 52)Mr. Kirk L. Somers, Chief Legal & People Officer (Age 54) When did Cardlytics IPO? (CDLX) raised $76 million in an initial public offering on Friday, February 9th 2018. The company issued 5,400,000 shares at $13.00-$15.00 per share. BofA Merrill Lynch and J.P. Morgan acted as the underwriters for the IPO and Wells Fargo Securities, SunTrust Robinson Humphrey, Raymond James and KeyBanc Capital Markets were co-managers. What is Cardlytics' stock symbol? Cardlytics trades on the NASDAQ under the ticker symbol "CDLX." How do I buy shares of Cardlytics? Shares of CDLX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Cardlytics' stock price today? One share of CDLX stock can currently be purchased for approximately $68.79. How big of a company is Cardlytics? Cardlytics has a market capitalization of $1.88 billion and generates $210.43 million in revenue each year. The company earns $-17,140,000.00 in net income (profit) each year or ($0.75) on an earnings per share basis. What is Cardlytics' official website? The official website for Cardlytics is www.cardlytics.com. How can I contact Cardlytics? Cardlytics' mailing address is 675 PONCE DE LEON AVENUE NE SUITE 6000, ATLANTA GA, 30308. The company can be reached via phone at 888-798-5802 or via email at [email protected] This page was last updated on 9/29/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
